ArticleMethods in molecular biology (Clifton, N.J.)2026
Gradient Descent to Predict Enzyme Inhibition.
Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This chapter describes the Gradient Descent method to predict the inhibition of protein targets. Protein systems are well-suited to study with artificial intelligence techniques, including machine learning methods. Here, we employ two variants of the Gradient Descent method: Batch Gradient Descent and Stochastic Gradient Descent. The last one is available in the Scikit-Learn library (SGDRegressor class). We can integrate Scikit-Learn methods into pipelines to build regression models addressing protein targets employed for drug discovery. In this work, we adopt a hands-on approach and show how to make a regression model to predict the inhibition of cyclin-dependent kinase 2, a protein target for anticancer drugs. We combine pair interaction data determined using the docking program AutoDock Vina and the SGDRegressor class implemented in the program SAnDReS 2.0 to create models to determine enzyme inhibition. All Jupyter Notebooks and datasets examined in this work are at GitHub: https://github.com/azevedolab/docking#readme . We made the program SAnDReS 2.0 available at https://github.com/azevedolab/sandres .
Indexed as
Identifiers
41075085What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.